Premium
Oncogene mutation and prognosis in the myelodysplastic syndromes
Author(s) -
Padua R. A.,
West R. R.
Publication year - 2000
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/j.1365-2141.2000.02472.x
Subject(s) - myelodysplastic syndromes , medicine , mutation , international prognostic scoring system , oncogene , oncology , cancer research , cancer , genetics , biology , gene , bone marrow , cell cycle
In a series of myelodysplastic syndrome patients, mutational status (particularly RAS mutation) was found to be prognostic for survival, independently of four previously reported scoring systems (Bournemouth, Sanz, Lille, International).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom